Positive Technologies announced the release of the commercial version of PT Dephaze. Automatic internal penetration testing system PT Dephaze allows companies to continuously and securely test their security and find weaknesses in their infrastructure before they are exploited by cybercriminals. Product will be available to users starting March 2025.

Positive Technologies acquired a stake in the Belarusian vendor Virusblokada. Investing in the developer of anti-virus protection tools allows the company to open new markets for itself, offering customers products depending on their maturity level, starting from the most basic level, where anti-virus technology is needed first of all.

Positive Technologies' shipments in 2024 deviated significantly from its original plan of ₽40-50 billion to around ₽26 billion. In its pre-release, the company attributed this to the key rate hike, which has significantly impacted customers' ability to expand their existing budgets. However, another reason cited today for the failure to meet the plan was the...

Positive Technologies' shipments in 2024 are expected to total ₽25.5 billion, remaining at the same level as the previous year. Performance was below management's initial expectations as Q4 saw a key rate hike, which significantly impacted customers' ability to expand their existing budgets. Positive Technologies management is currently updating the medium-t...